tapebrief
Preliminary brief— based on press release only. Full analysis including management tone and Q&A will be added when the transcript is available.

TDY · Q1 2026 Earnings

Teledyne Technologies

Reported April 22, 2026

30-second summary

Teledyne delivered $1.56B in Q1 revenue (+7.6% YoY) and $5.80 of non-GAAP EPS, beating its own $5.40–$5.50 guide by $0.30 at the high end, and raised FY2026 revenue to $6.365–$6.465B (+70bps at midpoint) and FY non-GAAP EPS to $23.85–$24.15 (+$0.35). The signal underneath the raise is that Aerospace & Defense Electronics organic growth held at +14.4% on a tougher comp, Digital Imaging margins expanded 107bps, and management lifted CapEx ~35% YoY because "demand is larger than capacity in certain areas" — the M&A-appetite story from Q4 has been joined by a capacity-expansion story this quarter.

Headline numbers

EPS

Q1 FY2026

$5.80

Revenue

Q1 FY2026

$1.56B

+7.6% YoY

Gross margin

Q1 FY2026

43.2%

Free cash flow

Q1 FY2026

$0.20B

Operating margin

Q1 FY2026

18.9%

Key financials

Q1 FY2026
MetricQ1 FY2026YoYQ4 FY2025QoQ
Revenue$1.56B+7.6%$1.61B-3.2%
EPS$5.80$6.30-7.9%
Gross margin43.2%42.9%+26bps
Operating margin18.9%20.4%-150bps
Free cash flow$0.20B$0.34B-39.8%

Guidance

Strong Q1 beat on non-GAAP EPS (+$0.30 above high end) drives full-year 2026 revenue and earnings guidance up 70 bps and $0.35 respectively.

Guidance is issued for both next quarter and the full year. Both may appear below.

Actuals vs prior guidance

MetricPeriodPrior guideActualΔResult
Non-GAAP EPSQ1 FY2026$5.40 to $5.50$5.8+$0.30 above high end of guideBeat

New guidance

MetricPeriodGuideYoY
GAAP EPSQ1 FY2026$4.85
GAAP EPSFY2026$20.08 to $20.44
Non-GAAP EPSQ2 FY2026$5.70 to $5.80
GAAP EPSQ2 FY2026$4.75 to $4.90

Changes to prior guidance

MetricPeriodPrior guideNew guideΔResult
Revenue
FY2026
$6.37 billion (midpoint)$6.365 billion to $6.465 billion+70 basis points at midpoint (from $6.37B to $6.415B)Raised
Non-GAAP EPS
FY2026
$23.45 to $23.85$23.85 to $24.15+$0.35 at midpoint (from $23.65 to $24.00); raised at both endsRaised

Product revenue

Q1 FY2026
SegmentQ1 FY2026YoY
Digital Imaging$0.817B+7.9%
Instrumentation$0.361B+5.3%
Aerospace and Defense Electronics$0.278B+14.4%
Engineered Systems$0.104B-2.6%
Digital Imaging Organic Revenue Growth7.9%
Aerospace and Defense Electronics Organic Revenue Growth14.4%

Management tone

Q2-2025 anchor: tariff pull-forward caution → Q3-2025 anchor: defense mix and stabilized Digital Imaging → Q4-2025 anchor: M&A appetite reactivated → Q1-2026 anchor: capacity expansion to meet demand.

The capital-allocation posture has rotated again — from buyback-over-M&A in Q2-2025, to "more encouraged" on M&A in Q4-2025, to capacity-led CapEx in Q1-2026. Three quarters ago Mehrabian was sitting on the M&A sidelines citing 19–20x EBITDA multiples; this quarter management lifted Q1 CapEx ~35% YoY while still pursuing acquisitions with leverage at a five-year low of 1.3x. From the call: "we've always been kind of very cautious with our money. That ought to tell you that we're kind of bullish about this area." The willingness to spend organic capital ahead of the demand curve is the strongest fundamental signal this team has issued in the four-quarter arc covered here.

Defense has progressed from a mix tailwind to a demand-exceeds-supply constraint. In Q2-2025 management quantified 15% YoY international defense growth as a structural tailwind; in Q3 it became ~$500M of annualized European defense with a multi-country production footprint; in Q4 it drove A&D Electronics +40.4% with heavy acquisition contribution; this quarter +14.4% is organic on the toughest comp yet, and the framing has hardened: "our demand is larger than our capacity in certain areas." The 35% CapEx step-up exists because of this constraint, not in spite of it.

Industrial inspection and healthcare flipped from headwind to tailwind, validating the Digital Imaging recovery thesis. Two quarters ago management declared DALSA E2V "stabilized"; this quarter the framing went further — "certain markets, such as industrial inspection and healthcare, which have had headwinds in the past, are now inflecting." Industrial machine vision for semi inspection and X-ray healthcare products grew YoY. The Digital Imaging recovery has progressed from "stabilizing" → "inflecting" across two quarters, with segment margin holding above 23%.

Instrumentation margin guidance is now a forward roadmap, not a recovery hope. In Q4-2025 Mehrabian hedged on segment margin upside with "with good luck, I hope we'll get to the 24%"; this quarter, despite Instrumentation posting its lowest-margin quarter, management committed to a quarter-by-quarter glidepath: "we're projecting 29% margin in the fourth quarter for that segment." The willingness to peg a specific Q4 number on a segment that just troughed signals confidence in the PCI Gen 6 / protocol-analyzer cycle returning in H2.

Hedging language remains the one defensive note. "I'm a little conservative, Noah, as you know us to be," and "We'll see how much budget goes in there in reality, right? Asking for increased budgets is one thing, getting it is another." Management raised guidance but explicitly attributed the call to "stronger sales and record orders and backlog" rather than projecting market-beating foresight — the same restraint signature visible in Q4.

Recurring themes management leaned on this quarter:

Defense demand acceleration (9% organic growth, orders 'way up') driven by geopolitical conflictsCapacity expansion investment (35% CapEx increase) to meet demand larger than supplyDigital imaging margin expansion (107 bps improvement) as FLIR and legacy businesses performBacklog at record levels with book-to-bill 1.16 (10th consecutive quarter >1.0)Industrial inspection and healthcare inflection ending prior headwindsInternational growth now 48% of portfolio, U.S. government 9% organic growth

Risks management surfaced:

Government procurement cycles remain 'tedious, even when there's urgent need' despite conflict demandForeign exchange headwinds moderating (2% in Q1 to 0.6% Q2 to 0% Q3-Q4)Test and measurement weak in Q1 due to protocol analyzer timing (PCI Gen 6 chips delayed to H2)M&A valuations 'outrageous' constraining larger deal pursuit outside portfolio focusSupply chain caution regarding China restrictions driving inventory investments

Answers to last quarter's watch list

Q1 FY2026 EPS vs. the $5.40–$5.50 guide — Non-GAAP EPS came in at $5.80, $0.30 above the high end (+5.5%) and matched by the top of the Q2 guide ($5.70–$5.80), implying the H1 earnings concentration management framed last quarter is intact and the FY guide carried meaningful conservatism. Status: Resolved positively
Whether ~4.2% inorganic growth shows up as announced deals in H1 2026 — No new acquisitions were announced this quarter; management instead deployed capital into 35% higher CapEx and described itself as "actively pursuing a number of acquisitions" with leverage at a five-year low. The inorganic component of the FY guide is not yet de-risked, but the FY revenue raise of $45M was achieved organically. Status: Continue monitoring
Digital Imaging segment margin holding above 24% — Segment margin was 23.2% in Q1, below the 24%+ Q4-2025 print, though up 107bps YoY. Q1 is the segment's seasonally lowest-margin quarter; the structural step-up case is not yet falsified but not yet confirmed either. Status: Continue monitoring
A&D Electronics YoY growth above +30% and segment book-to-bill — Growth came in at +14.4%, well below the +30% threshold, but on a +40.4% prior-year comp and entirely organic. Segment book-to-bill not separately disclosed in the press release; overall company book-to-bill 1.16x. Below the threshold on the headline number, but the comp and organic mix make the underlying read more durable than the % suggests. Status: Continue monitoring
Engineered Systems revenue inflection — Down 2.6% YoY, materially improved from Q4's -9.9%. Conversion of contract opportunities into bookings is showing in the trajectory if not yet in positive growth. Status: Continue monitoring
Specific updates on Rogue One USMC OPFL and U.S. Army LASSO — No specific award commentary on either program in the available disclosure. The unmanned-systems catalysts Mehrabian flagged in Q3-2025 remain unresolved; management discussed munitions replacement demand from Middle East conflicts qualitatively but did not name awards. Status: Continue monitoring

What to watch into next quarter

Q2 non-GAAP EPS vs. the $5.70–$5.80 guide — the top of the guide already matches the Q1 print; a clean Q2 above $5.80 confirms the H1 trajectory and the case for further FY raises in H2.

Whether Instrumentation segment margin steps up sequentially from the Q1 trough toward management's 29% Q4 target — the FY EPS raise depends materially on this glidepath holding; Q2 margin below Q1's level would be a meaningful negative signal.

A&D Electronics organic growth sustaining double-digit on the Q2 FY2025 comp — Q2-2025 grew 36.2%; the segment needs to clear a similar bar to the one it cleared this quarter, and management's "demand exceeds capacity" framing requires the print to confirm it.

Capacity-expansion CapEx running rate — Q1 CapEx of $29.7M is the leading indicator of how seriously management is treating the demand constraint; sustained 30%+ YoY CapEx growth signals the defense ramp is multi-year, while a deceleration would suggest the Q1 step-up was a pull-in.

Any M&A announcement — with leverage at 1.3x and management still describing itself as "actively pursuing" deals, absence of announced transactions by Q3 would force a re-assessment of the ~4.2% inorganic growth baked into the FY guide.

Digital Imaging segment margin recovering above 24% as the year progresses — Q1's 23.2% is acceptable as a seasonal trough; Q2 above 24% confirms the structural step-up, Q2 below 24% calls it into question.

Sources

  1. Teledyne Q1 2026 earnings release (SEC filing): https://www.sec.gov/Archives/edgar/data/1094285/000109428526000024/q1-2026earningsrelease.htm
  2. Teledyne Q1 2026 earnings call prepared remarks and Q&A — management commentary attributed to Robert Mehrabian (Executive Chairman) and George Bobb (President & CEO)
  3. Tapebrief Q4 2025, Q3 2025, and Q2 2025 TDY briefs (prior-quarter trend context)

Get the next brief, free.

We publish analyst-grade earnings briefs the same day or morning after every call — headline numbers, segment KPIs, Q&A highlights, and tone analysis. Free during beta.

This is not investment advice.